跳至主要内容
临床试验/ITMCTR2000003976
ITMCTR2000003976
尚未招募
1 期

Multi center randomized controlled clinical trial of Xiezhuo Tongluo Formula in the treatment of chronic kidney disease stage 3-4

The First Affiliated Hospital of Guangzhou University of Chinese Medicine0 个研究点待定

概览

阶段
1 期
干预措施
未指定
疾病 / 适应症
未指定
发起方
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
状态
尚未招募
最后更新
3年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
3年前
研究类型
Interventional study
性别
All

研究者

发起方
The First Affiliated Hospital of Guangzhou University of Chinese Medicine

入排标准

入选标准

  • (1\) It met the diagnostic criteria of CKD3\-4
  • (2\) Aged 18 to 75 years old and can sign the informed consent form independently
  • (3\) Blood pressure 100\-160/60\-100mmHg.

排除标准

  • (1\) Prepare for renal replacement therapy;
  • (2\) Immunosuppressive therapy were performed;
  • (3\) Patients with acute infection, serious primary diseases of heart, lung, brain, liver and hematopoietic system, diabetic ketoacidosis, malignant tumor, active tuberculosis and psychotic patients;
  • (4\) eGFR fluctuated more than 30% in three months;
  • (5\) Severe hyperkalemia (blood potassium\>6\.5mmol/L);
  • (6\) Allergy history to some components of the drug used;
  • (7\) Pregnant or during lactation;
  • (8\) Participated in other clinical studies.

结局指标

主要结局

未指定

相似试验